• Citer

Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapy.

par Fonseca, P J;Esteban, Emilio;de Vicente, P;Luque, Miguel;Llorente, Bertrand;Capelan, Marta ;Berros, J P;Crespo, G;Lacave, Ángel Jiménez
Référence Clinical & translational oncology, 10, 7, page (426-432)
Publication Publié, 2008-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapy.
Auteur:	Fonseca, P J; Esteban, Emilio; de Vicente, P; Luque, Miguel; Llorente, Bertrand; Capelan, Marta; Berros, J P; Crespo, G; Lacave, Ángel Jiménez
Informations sur la publication:	Clinical & translational oncology, 10, 7, page (426-432)
Statut de publication:	Publié, 2008-07
Sujet CREF:	Cancérologie
	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Anemia -- chemically induced -- drug therapy
	Antineoplastic Agents -- adverse effects
	Blood Transfusion
	Erythropoietin -- therapeutic use
	History, 17th Century
	Humans
	Kaplan-Meier Estimate
	Lung Neoplasms -- drug therapy -- mortality
	Quality of Life
	Recombinant Proteins
	Retrospective Studies
Note générale:	Historical Article
	Journal Article
Langue:	Anglais
Identificateurs:	urn:issn:1699-048X
	info:pii/CLAT51
	info:pmid/18628072